Literature DB >> 27818333

Pulmonary Hypertension Care Center Network: Improving Care and Outcomes in Pulmonary Hypertension.

Sandeep Sahay1, Lana Melendres-Groves2, Leena Pawar3, Hector R Cajigas4.   

Abstract

Pulmonary hypertension (PH) is a chronic, progressive, life-threatening disease that requires expert multidisciplinary care. To facilitate this level of care, the Pulmonary Hypertension Association established across the United States a network of pulmonary hypertension care centers (PHCCs) with special expertise in PH, particularly pulmonary arterial hypertension, to raise the overall quality of care and outcomes for patients with this life-threatening disease. Since the inception of PHCCs in September 2014, to date 35 centers have been accredited in the United States. This model of care brings together physicians and specialists from other disciplines to provide care, facilitate basic and clinical research, and educate the next generation of providers. PHCCs also offer additional opportunities for improvements in PH care. The patient registry offered through the PHCCs is an organized system by which data are collected to evaluate the outcomes of patients with PH. This registry helps in detecting variations in outcomes across centers, thus identifying opportunities for improvement. Multiple tactics were undertaken to implement the strategic plan, training, and tools throughout the PHCC network. In addition, strategies to foster collaboration between care center staff and individuals with PH and their families are the cornerstone of the PHCCs. The Pulmonary Vascular Network of the American College of Chest Physicians believes this to be a positive step that will improve the quality of care delivered in the United States to patients with PH.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PHCCs; outcomes; pulmonary arterial hypertension; pulmonary hypertension; pulmonary hypertension care centers

Mesh:

Year:  2016        PMID: 27818333     DOI: 10.1016/j.chest.2016.10.043

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Outcomes of Pulmonary Arterial Hypertension Are Improved in a Specialty Care Center.

Authors:  Hongyang Pi; Chad M Kosanovich; Adam Handen; Michael Tao; Jacqueline Visina; Gabrielle Vanspeybroeck; Marc A Simon; Michael G Risbano; Aken Desai; Michael A Mathier; Belinda N Rivera-Lebron; Quyen Nguyen; Jennifer Kliner; Mehdi Nouraie; Stephen Y Chan
Journal:  Chest       Date:  2020-02-25       Impact factor: 9.410

2.  Improved hospitalization rates in a specialty center for heart failure with preserved ejection fraction and pulmonary hypertension.

Authors:  Chad M Kosanovich; Hongyang Pi; Adam Handen; Erin Schikowski; Yimin Chen; Floyd W Thoma; Suresh Mulukutla; Steve Koscumb; Mehdi Nouraie; Stephen Y Chan
Journal:  Pulm Circ       Date:  2022-06-07       Impact factor: 2.886

3.  The burden of comorbidities in pulmonary arterial hypertension.

Authors:  Irene M Lang; Massimiliano Palazzini
Journal:  Eur Heart J Suppl       Date:  2019-12-17       Impact factor: 1.803

4.  Comparing Diagnosis and Treatment of Pulmonary Hypertension Patients at a Pulmonary Hypertension Center versus Community Centers.

Authors:  Hollie Saunders; Scott A Helgeson; Ahmed Abdelrahim; Kathleen Rottman-Pietrzak; Victoria Reams; Tonya K Zeiger; John E Moss; Charles D Burger
Journal:  Diseases       Date:  2022-01-07

5.  Building a dedicated pediatric pulmonary hypertension program: A consensus statement from the pediatric pulmonary hypertension network.

Authors:  Stephanie S Handler; Nidhy P Varghese; Erika B Rosenzweig; Delphine Yung; Usha Krishnan; Elise Whalen; Angela Bates; Catherine M Avitabile; Emma O Jackson; Russel Hirsch; Jeffrey Fineman; Steven H Abman
Journal:  Pulm Circ       Date:  2022-02-15       Impact factor: 2.886

6.  Evaluation, Diagnosis, and Classification of Pulmonary Hypertension.

Authors:  Beshay Sarah; Guha Ashrith; Sahay Sandeep
Journal:  Methodist Debakey Cardiovasc J       Date:  2021-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.